Skip To Main Content
Jonathan Hibbard on Muck Rack

Jonathan Hibbard

As seen in: Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jonathan

Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety

|
By Michael Barish, Julie R. Ostberg, Jamie Wagner, Mishika Manchanda, Jinny Paul, Brenda Aguilar, Renate Starr, Leonidas D. Arvanitis, Julie A. Ressler, Dongrui Wang, Stephen J. Forman, Massimo D’Apuzzo, Behnam Badie, Maryam Aftabizadeh, Jonathan Hibbard, M. Suzette Blanchard, Tracy Stiller, Julie Kilpatrick, Yuthana Kong
| Cell Reports Medicine Verified
Keywords chlorotoxin chimeric antigen receptor T cells immunotherapy phase 1 clinical trial Introduction Glioblastoma (GBM; isocitrate dehydrogenase (IDH)-wild-type World Health Organization [WHO] grade 4) is the most aggressive brain neoplasm.
Open in Who Shared Issue with article?
See all 1 articles